The California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to UC San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis.
Related Articles

News
UC San Diego Library and San Diego Natural History Museum Collaborate to Raise Awareness
August 11, 2022
sandiegobiotech
News, UCSD News
Comments Off on UC San Diego Library and San Diego Natural History Museum Collaborate to Raise Awareness
Today, the UC San Diego Library announced its new community partnership with the San Diego Natural History Museum (The Nat), which has resulted in an art exhibit that will be featured at the Balboa Park museum a… […]

Industry News
Complex Sugars and Microbiome in Mother?s Milk Influence Neonatal Rotavirus Infection
November 27, 2018
sandiegobiotech
Industry News, News
Comments Off on Complex Sugars and Microbiome in Mother?s Milk Influence Neonatal Rotavirus Infection

News
First Case of Community Acquired Omicron Variant in San Diego
December 10, 2021
sandiegobiotech
News, UCSD News
Comments Off on First Case of Community Acquired Omicron Variant in San Diego
Few places in the country are better equipped to detect new virus variants than San Diego, where researchers at UC San Diego School of Medicine and Scripps Research, working with county public health officials, … […]